Trademark: 75542062
Status Date
Friday, October 1, 2010
Registration Number
2815937
Registration Date
Tuesday, February 24, 2004
Filing Date
Monday, August 24, 1998
Published for Opposition
Tuesday, December 2, 2003
Cancellation Date
Friday, October 1, 2010
5 Pharmaceuticals for therapeutic and diagnostic uses in the treatment of cardiovascular disease, immune disorders, and inflammation; vaccines and purified proteins for therapeutic and diagnostic use
The word "AVANT" appearing as part of the composite mark AVANT plus design means "BEFORE" in French.
Oct 1, 2010
Cancelled Sec. 8 (6-Yr)
Feb 24, 2004
Registered-Principal Register
Dec 2, 2003
Published For Opposition
Nov 12, 2003
Notice Of Publication
Sep 8, 2003
Allowed Principal Register - Sou Accepted
Jul 24, 2003
Correspondence Received In Law Office
Aug 27, 2003
Case File In Ticrs
Jul 24, 2003
Paper Received
Jul 2, 2003
Non-Final Action E-Mailed
Jun 17, 2003
Assigned To Examiner
Jun 17, 2003
Assigned To Examiner
Jun 10, 2003
Statement Of Use Processing Complete
Mar 28, 2003
Use Amendment Filed
Mar 10, 2003
Extension 3 Granted
Feb 28, 2003
Extension 3 Filed
Oct 10, 2002
Extension 2 Granted
Aug 28, 2002
Extension 2 Filed
Apr 30, 2003
Petition To Revive-Granted
Mar 31, 2003
Petition To Revive-Received
Mar 31, 2003
Paper Received
Mar 8, 2003
Abandonment - No Use Statement Filed
Aug 26, 2002
Teas Change Of Correspondence Received
Mar 7, 2002
Extension 1 Granted
Feb 27, 2002
Extension 1 Filed
Aug 28, 2001
Noa Mailed - Sou Required From Applicant
Jun 5, 2001
Published For Opposition
May 23, 2001
Notice Of Publication
Jan 16, 2001
Approved For Pub - Principal Register
Jun 8, 2000
Correspondence Received In Law Office
Dec 9, 1999
Non-Final Action Mailed
Jul 26, 1999
Correspondence Received In Law Office
Feb 19, 1999
Non-Final Action Mailed
Feb 12, 1999
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
